140 related articles for article (PubMed ID: 32442541)
1. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
[TBL] [Abstract][Full Text] [Related]
2. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
Vahednia E; Shandiz FH; Bagherabad MB; Moezzi A; Afzaljavan F; Tajbakhsh A; Kooshyar MM; Pasdar A
Clin Breast Cancer; 2019 Oct; 19(5):e563-e577. PubMed ID: 31362911
[TBL] [Abstract][Full Text] [Related]
3. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
4. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
5. Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population.
Srivastava K; Srivastava A; Mittal B
Mol Carcinog; 2010 Jul; 49(7):684-92. PubMed ID: 20564345
[TBL] [Abstract][Full Text] [Related]
6. Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran.
Afzaljavan F; Vahednia E; Barati Bagherabad M; Vakili F; Moezzi A; Hosseini A; Homaei Shandiz F; Kooshyar MM; Nassiri M; Pasdar A
BMC Med Genomics; 2023 Apr; 16(1):72. PubMed ID: 37016353
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
8.
Ying Y; Xu J; Qi Y; Zhang M; Yang Y
J Cancer; 2018; 9(22):4166-4171. PubMed ID: 30519316
[No Abstract] [Full Text] [Related]
9. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
[TBL] [Abstract][Full Text] [Related]
10. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
11. Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
Shih LC; Tsai CW; Sun KT; Hsu HM; Shen TC; Tsai YT; Chang WS; Lin ML; Wang YC; Gong CL; Bau DT
In Vivo; 2019; 33(4):1151-1156. PubMed ID: 31280204
[TBL] [Abstract][Full Text] [Related]
12. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
[TBL] [Abstract][Full Text] [Related]
13. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
[TBL] [Abstract][Full Text] [Related]
14. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
Li Z; Wang J; Wang F; Ma Z; Yu Z
Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
[TBL] [Abstract][Full Text] [Related]
15. Association between CASP-8 gene polymorphisms and cancer risk in some Asian population based on a HuGE review and meta-analysis.
Zhang YJ; Zhong XP; Chen Y; Liu SR; Wu G; Liu YF
Genet Mol Res; 2013 Feb; 12(4):6466-76. PubMed ID: 23479148
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
[TBL] [Abstract][Full Text] [Related]
18. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
[TBL] [Abstract][Full Text] [Related]
20. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]